Smooth initiates a phase II trial in patients with chronic HDV

Phase II trials are planned when the drug has demonstrated acceptable safety profile in phase I study. The main objectives of these studies are safety assessment, selection of administration regimens and doses in patiens.

If necessary, we involve our referral network, provide sites with trained personnel, as well as help to obtain approvals and training for newbie sites.